Opportunity Information: Apply for PA 07 050

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "Ancillary Studies of Kidney Disease Accessing Information from Clinical Trials, Epidemiological Studies, and Databases (R01)" and is now available to receive applicants.
  • This funding opportunity was created on May 28, 2009 and posted on Nov 21, 2006.
  • Applicants must submit their applications by Sep 7, 2009 Multiple Receipt Dates See Link to Full Announcement for details.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: County governments Others (see text field entitled Additional Information on Eligibility for clarification) State governments Public and State controlled institutions of higher education Independent school districts Native American tribal governments (Federally recognized) Small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities City or township governments Special district governments Private institutions of higher education For profit organizations other than small businesses.
  • Foreign institutions are eligible to apply. Eligible agencies of the Federal Government can apply. Faith based or community based organizations can apply.
Apply for PA 07 050

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The NIH, through the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), offered this R01 grant opportunity to support investigator-initiated ancillary studies that leverage information from existing or ongoing research efforts to advance knowledge about kidney disease. The core idea is to build on the value of clinical trials, epidemiological studies, and large datasets that already exist by adding new questions, new measurements, or new analyses that were not part of the original project aims but can be addressed using the same participant cohorts, infrastructure, or stored data and specimens. In practical terms, this program is meant to help researchers get more scientific return from prior investments by reusing high-quality data sources, extending follow-up, or collecting additional kidney-relevant information in studies that are already underway.

The kinds of ancillary work encouraged under this announcement include both low-burden and more involved approaches. On the lower-burden end, applicants could propose new analyses of completed studies using existing datasets, including large public-access databases or other established repositories. On the more involved end, applicants could propose additional data collection or the collection of biological specimens in ongoing investigations, as long as the work is clearly positioned as an add-on to an existing clinical trial or epidemiological study rather than a completely standalone project. Importantly, the parent study does not have to be a kidney-only study; trials and cohort studies focused on other diseases or populations are also considered appropriate if they provide a meaningful opportunity to examine kidney outcomes, kidney risk factors, or kidney-related complications.

Scientifically, the announcement emphasizes research that improves understanding of (1) risk factors for developing kidney disease and the co-morbid conditions that often travel with it, (2) factors tied to faster loss of kidney function among people who already have chronic kidney disease (CKD), and (3) how kidney disease affects daily life, including quality of life and both mental and physical functioning. The description specifically calls out co-morbid illnesses such as malnutrition and cardiovascular disease as areas of interest, reflecting the real-world reality that kidney disease is often intertwined with broader metabolic and cardiovascular health. The announcement also highlights biomarker studies as an appropriate direction, including work focused on patients with acute renal failure (acute kidney injury) and other kidney diseases, suggesting an interest in tools that could improve risk prediction, early detection, disease phenotyping, or monitoring.

Another notable feature is that NIDDK explicitly encourages ancillary studies linked to both government-supported and non-government-supported trials and epidemiological studies. That widens the pool of possible “parent” studies and signals that the key requirement is the scientific opportunity and feasibility of meaningful kidney-related ancillary aims, not the funding source of the original project. In addition, the encouragement of analyses using large public-access databases indicates that proposals did not necessarily need access to a proprietary cohort, as long as the dataset is robust enough to answer important kidney-related questions.

Administratively, this was a discretionary NIH funding opportunity using the R01 research project grant mechanism, and it did not require cost sharing or matching. The eligible applicant list was broad, spanning state, local, and tribal governments; public and private institutions of higher education; nonprofit organizations (including those with and without 501(c)(3) status); small businesses and other for-profit organizations (with limits noted in the eligibility text); public housing authorities; school districts; and other special district governments. Eligibility also extended to foreign institutions, eligible federal agencies, and faith-based or community-based organizations, which is relatively inclusive compared with some NIH announcements and suggests the program was open to diverse institutional settings capable of conducting rigorous ancillary research.

Key dates in the source information show that the opportunity was posted on November 21, 2006 (PA-07-050), with multiple receipt dates and a final listed closing date of September 7, 2009, followed by an archive date of October 8, 2009. The full announcement was hosted through the NIH grants guide, and general technical assistance for accessing the announcement was directed to the NIH Office of Extramural Research (OER) webmaster contact listed in the notice.

Frequently Asked Questions (FAQs)

What is this NIH funding opportunity about?

This NIH opportunity, offered through the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), supports investigator-initiated ancillary studies that use information, infrastructure, participants, or specimens from existing or ongoing research efforts to advance knowledge about kidney disease.

What does "ancillary study" mean in this program?

In this context, an ancillary study is an add-on project that is linked to a completed or ongoing parent study (such as a clinical trial or epidemiological/cohort study). The ancillary work asks new questions, adds new measurements, extends follow-up, or performs new analyses that were not part of the parent study's original aims, while leveraging the parent study's existing resources.

What is the main purpose of funding ancillary studies instead of entirely new studies?

The program is intended to increase scientific return from prior research investments by reusing high-quality data sources and study infrastructure. Examples include reanalyzing existing datasets, extending follow-up in ongoing cohorts, or collecting additional kidney-relevant information in studies already underway.

What types of parent studies can an ancillary project build on?

Ancillary projects can build on existing or ongoing clinical trials, epidemiological studies, and large datasets. The parent study does not need to be focused exclusively on kidney disease; studies focused on other diseases or populations can be appropriate if they provide a meaningful opportunity to examine kidney outcomes, risk factors, or complications.

Do ancillary studies have to be linked to government-funded parent studies?

No. NIDDK explicitly encourages ancillary studies connected to both government-supported and non-government-supported trials and epidemiological studies. The emphasis is on scientific opportunity and feasibility rather than the original funding source of the parent study.

Can an application be based only on data analysis, without collecting new data?

Yes. Lower-burden ancillary work specifically encouraged includes new analyses of completed studies using existing datasets, including large public-access databases and other established repositories.

Can an ancillary study include new data collection or collection of biological specimens?

Yes. More involved approaches are allowed, including additional data collection or collection of biological specimens in ongoing investigations, as long as the work is clearly positioned as an add-on to an existing trial or epidemiological study and not a completely standalone project.

Are studies using large public-access databases allowed?

Yes. The announcement encourages analyses using large public-access databases, indicating that proposals do not necessarily need proprietary cohort access as long as the dataset is robust enough to address important kidney-related questions.

What kidney research topics are emphasized in the announcement?

The announcement emphasizes research that improves understanding of: (1) risk factors for developing kidney disease and related co-morbid conditions, (2) factors associated with faster loss of kidney function among people with chronic kidney disease (CKD), and (3) how kidney disease affects daily life, including quality of life and mental and physical functioning.

Does the opportunity mention co-morbidities associated with kidney disease?

Yes. It highlights co-morbid illnesses that often accompany kidney disease, specifically calling out malnutrition and cardiovascular disease as areas of interest.

Are biomarker studies within scope?

Yes. Biomarker studies are identified as an appropriate direction, including work involving patients with acute renal failure (acute kidney injury) and other kidney diseases. The emphasis suggests interest in tools for risk prediction, early detection, disease phenotyping, or monitoring.

Is this a specific NIH grant mechanism?

Yes. This was an NIH discretionary funding opportunity using the R01 research project grant mechanism.

Does the opportunity require cost sharing or matching funds?

No. The source information states that this opportunity did not require cost sharing or matching.

Who is eligible to apply?

The eligible applicant list is broad and includes state, local, and tribal governments; public and private institutions of higher education; nonprofit organizations (with and without 501(c)(3) status); small businesses and other for-profit organizations (with limits noted in the eligibility text); public housing authorities; school districts; and other special district governments. Eligibility also extends to foreign institutions, eligible federal agencies, and faith-based or community-based organizations.

Does the opportunity allow foreign institutions to apply?

Yes. Foreign institutions are included in the eligible applicant categories described in the source information.

What is the opportunity identification and when was it posted?

The opportunity was posted on November 21, 2006, and is identified as PA-07-050.

What were the key dates (closing and archive dates)?

The source information indicates multiple receipt dates, a final listed closing date of September 7, 2009, and an archive date of October 8, 2009.

Where was the full announcement hosted?

The full announcement was hosted through the NIH grants guide.

Who was listed for technical assistance with accessing the announcement?

General technical assistance for accessing the announcement was directed to the NIH Office of Extramural Research (OER) webmaster contact listed in the notice.

Browse more business programs for Kidney Disease Research

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: Calcium Oxalate Stone Diseases (R01)

Previous opportunity: Drug Discovery for Nervous System Disorders (R01)

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PA 07 050

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (PA 07 050) also looked into and applied for these:

Funding Opportunity
Calcium Oxalate Stone Diseases (R01) Apply for PA 07 051

Funding Number: PA 07 051
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Pancreatic Development and Regeneration Toward Cellular Therapies for Diabetes (R01) Apply for PA 07 056

Funding Number: PA 07 056
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Research On Adherence To Interventions For Mental Disorders (R01) Apply for PA 07 076

Funding Number: PA 07 076
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Pathophysiology and Treatment Response in Late Life Mood and Anxiety Disorders (R01) Apply for PA 07 077

Funding Number: PA 07 077
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Indo U.S. Vaccine Action Program (VAP) Small Research Grant Program (R03) Apply for PA 07 093

Funding Number: PA 07 093
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Effectiveness, Practice, And Implementation In CMHS Comprehensive Community Mental Health Services Program for Children and their Families Service Sites (R01) Apply for PA 07 091

Funding Number: PA 07 091
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
The Central Processing of Taste Information (R01) Apply for PA 07 094

Funding Number: PA 07 094
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIDCD Patient Oriented Research Grant (R01) Apply for PA 07 095

Funding Number: PA 07 095
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Targeting Calcium Regulatory Molecules for Arrhythmia Prevention (R01) Apply for PA 07 101

Funding Number: PA 07 101
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Elucidating Nature s Solutions to Heart, Lung, and Blood Diseases and Sleep Disorder Processes (R01) Apply for PAR 07 102

Funding Number: PAR 07 102
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Research Opportunities in Stuttering (R01) Apply for PA 07 124

Funding Number: PA 07 124
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Cell Lineage and Developmental Studies in Hearing and Balance (R01) Apply for PA 07 127

Funding Number: PA 07 127
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Evolution of Infectious Diseases (R01) Apply for PA 07 130

Funding Number: PA 07 130
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Community Based Participatory Research at NIMH (R01) Apply for PAR 07 133

Funding Number: PAR 07 133
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Integrating Lung Genetics and Genomics in Human Populations (R01) Apply for PA 07 135

Funding Number: PA 07 135
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Protein Interactions Governing Membrane Transport in Pulmonary Health and Disease (R01) Apply for PA 07 137

Funding Number: PA 07 137
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
The Relationship Between Hypertension and Inflammation (R01) Apply for PA 07 138

Funding Number: PA 07 138
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Oral Health of Special Needs and Older Populations (R01) Apply for PA 07 151

Funding Number: PA 07 151
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Early Identification and Treatment of Mental Disorders in Children and Adolescents (R01) Apply for PA 07 158

Funding Number: PA 07 158
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Temporomandibular Joint and Muscle Disorders Pathophysiological Mechanisms Linking Comorbid Conditions (R01) Apply for PA 07 150

Funding Number: PA 07 150
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PA 07 050", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.